ask="0.7600"
ask_size="3000"
average_daily_volume="572651"
bid="N/A"
bid_size="N/A"
book_value="0.8130"
change="+0.0399"
change_from_200_day_moving_average="0.0995"
change_from_50_day_moving_average="0.0423"
change_from_52_week_high="-0.8000"
change_From_52_week_low="0.2889"
change_in_percent="+6.8793%"
close="0.6199"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.5350"
ebitda="-17.93M"
eps_estimate_current_year="-0.7800"
eps_estimate_next_quarter="-0.2900"
eps_estimate_next_year="-0.5700"
ex_dividend_date="N/A"
float_shares="29627000"
high="0.6500"
high_52_weeks="1.4199"
last_trade_date="2/21/2017"
last_trade_price="0.6199"
last_trade_size="106"
last_trade_time="3:54pm"
low="0.6000"
low_52_weeks="0.3310"
market_capitalization="18.61M"
moving_average_200_day="0.5204"
moving_average_50_day="0.5776"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.9000"
open="0.6000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+19.1105%"
percent_change_from_50_day_moving_average="+7.3147%"
percent_change_from_52_week_high="-56.3420%"
percent_change_from_52_week_low="+87.2810%"
previous_close="0.5800"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.7134"
price_per_sales="1.5706"
revenue="11.09M"
shares_outstanding="30020000"
short_ratio="1.1100"
stock_exchange="NCM"
symbol="OGXI"
volume="499708"
weeks_range_52="0.3310 - 1.4199"
